Results 61 to 70 of about 3,047,819 (288)

Peripartum Cardiomyopathy: An Analysis of Clinical Profiles and Outcomes from a Tertiary Care Center in Northern India

open access: yesJournal of Indian College of Cardiology
Objective: The present study was conducted to evaluate the clinical profile, and risk factors of peripartum cardiomyopathy (PPCM) and its association with maternal and fetal outcomes from a tertiary care center in Northern India.
Aqdas Mumtaz   +3 more
doaj   +1 more source

Tingkat pengetahuan ibu tentang pemantauan gerakan janin pada ibu hamil dengan preeklampsia

open access: yesJurnal Cakrawala Promkes, 2021
Preeclampsia is a pregnancy complication that can cause fetal and maternal morbidity and mortality. One way that pregnant women can reduce the risk of pregnancy complications is by monitoring the fetus's movement.
Fitri Yani   +2 more
doaj   +1 more source

Trends and characteristics of fetal and neonatal mortality due to congenital anomalies, Colombia 1999–2008

open access: yesJournal of Maternal-Fetal & Neonatal Medicine, 2017
Objective: To describe fetal and neonatal mortality due to congenital anomalies in Colombia. Methods: We analyzed all fetal and neonatal deaths due to a congenital anomaly registered with the Colombian vital statistics system during 1999–2008.
C. Roncancio   +5 more
semanticscholar   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

ANÁLISIS DE LA MORTALIDAD PERINATAL, HOSPITAL MIGUEL SERVET, ZARAGOZA, ESPAÑA: 2000-2009

open access: yesRevista Chilena de Obstetricia y Ginecología, 2011
Objetivos: Evaluar la mortalidad perinatal (MP) del Hospital Miguel Servet (2000-2009). Valorar su evolución, distribución según edad gestacional y peso de los recién nacidos (RN), y las posibles causas.
Esther Cruz G   +5 more
doaj  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Cumulative incidence of lethal congenital anomalies in Peru

open access: yesRevista de la Facultad de Medicina, 2020
Introduction: Lethal congenital anomalies (LCA) are anomalies associated with early stillbirth or newborn death. Currently, there are no data on the incidence of LCAs in Peru.
Alvaro Taype-Rondan   +3 more
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy